We are live on ! Find out more
VYGR icon

Voyager Therapeutics

132 hedge funds and large institutions have $331M invested in Voyager Therapeutics in 2024 Q1 according to their latest regulatory filings, with 33 funds opening new positions, 56 increasing their positions, 29 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

371% more first-time investments, than exits

New positions opened: 33 | Existing positions closed: 7

93% more repeat investments, than reductions

Existing positions increased: 56 | Existing positions reduced: 29

44% more capital invested

Capital invested by funds: $230M → $331M (+$102M)

23% more funds holding

Funds holding: 107132 (+25)

3.68% more ownership

Funds ownership: 61.81%65.49% (+3.7%)

17% less call options, than puts

Call options by funds: $579K | Put options by funds: $700K

Holders
132
Holders Change
+25
Holders Change %
+23.36%
% of All Funds
1.9%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
33
Increased
56
Reduced
29
Closed
7
Calls
$579K
Puts
$700K
Net Calls
-$121K
Net Calls Change
-$307K

VYGR Hedge Fund Activity: Q1 2024 in Review

132 of the 6,943 institutional investors tracked by Wall St. Rank reported a position in Voyager Therapeutics (VYGR) for Q1 2024, worth a combined $331M — up 44% from $230M a quarter earlier.

Buyers outnumbered sellers: 33 funds opened new VYGR positions and 7 closed out — a net gain of 26 holders — while 56 added to existing stakes and 29 trimmed.

The largest buyer was BlackRock, adding an estimated $14.9M. The largest seller was Morgan Stanley, cutting an estimated $1.73M.

  • 132 institutional investors held Voyager Therapeutics (VYGR) as of Q1 2024, up from 107 in Q4 2023.
  • Funds reported $331M of Voyager Therapeutics stock for Q1 2024, up 44% quarter-over-quarter.
  • 33 funds opened new Voyager Therapeutics positions in Q1 2024 and 7 closed out, a net change of +26 holders.
  • The largest Voyager Therapeutics buyer in Q1 2024 was BlackRock, an estimated $14.9M added.
  • The largest Voyager Therapeutics seller in Q1 2024 was Morgan Stanley, an estimated $1.73M sold.

Based on aggregated 13F filings for Q1 2024.